Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Large granular lymphocyte leukaemia occurring after renal transplantation BRITISH JOURNAL OF HAEMATOLOGY Gentile, T. C., Hadlock, K. G., Uner, A. H., Delal, B., Squiers, E., CROWLEY, S., Woodman, R. C., Foung, S. K., Poiesz, B. J., Loughran, T. P. 1998; 101 (3): 507-512

Abstract

Post-transplantation lymphoproliferative disorders (PTLD) are a clinicopathologically heterogeneous group of lymphoid proliferations. The majority are of B-cell origin and associated with Epstein-Barr virus (EBV) infection. In contrast, the development of T-cell PTLD is much less common and EBV does not appear to be involved in pathogenesis. In this report we describe three patients who developed large granular lymphocyte (LGL) leukaemia after renal transplantation. These patients had clonal expansion of CD3+, CD8+, CD57+, CD56- LGL. We were unable to detect CMV antigen or find evidence for EBV or human T-cell leukaemia/lymphoma virus genome in the LGL from these patients. These data show that LGL leukaemia should be included as one of the types of T-cell proliferations which can occur post transplant.

View details for Web of Science ID 000074236100019

View details for PubMedID 9633895